[HTML][HTML] MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
…, R Alagna, A Rendon, E Pontali, A Piubello… - International Journal of …, 2020 - Elsevier
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …
[HTML][HTML] Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020
…, F Palmieri, P Piccioni, A Piubello… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease has disrupted tuberculosis services globally. Data from 33 centers in 16
countries on 5 continents showed that attendance at tuberculosis centers was lower during …
countries on 5 continents showed that attendance at tuberculosis centers was lower during …
[HTML][HTML] Short-course regimen for multidrug-resistant tuberculosis: a decade of evidence
A Trébucq, T Decroo, A Van Deun, A Piubello… - Journal of clinical …, 2019 - mdpi.com
About ten years ago, the first results of the so-called “Bangladesh regimen”, a short regimen
lasting nine months instead of 20 months, revolutionized multidrug-resistant tuberculosis (…
lasting nine months instead of 20 months, revolutionized multidrug-resistant tuberculosis (…
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
A Piubello, SH Harouna… - … of Tuberculosis and …, 2014 - ingentaconnect.com
SETTING: Niger National Tuberculosis Programme. Regions supported by the Damien
Foundation.OBJECTIVE: To evaluate the effectiveness of a short-course standardised treatment …
Foundation.OBJECTIVE: To evaluate the effectiveness of a short-course standardised treatment …
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
…, J Bruchfeld, A Koleva, A Piubello… - European …, 2019 - Eur Respiratory Soc
The World Health Organization (WHO) recommends that countries implement pharmacovigilance
and collect information on active drug safety monitoring (aDSM) and management of …
and collect information on active drug safety monitoring (aDSM) and management of …
[HTML][HTML] Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
…, M Ferrarese, J Bruchfeld, A Koleva, A Piubello… - Pulmonology, 2021 - Elsevier
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
…, J Noeske, N Parpieva, A Piubello… - European …, 2020 - Eur Respiratory Soc
We sought to compare the effectiveness of two World Health Organization (WHO)-recommended
regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB…
regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB…
[HTML][HTML] Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
…, DJ Palmero, F Palmieri, MC Payen, A Piubello… - International journal of …, 2019 - Elsevier
The World Health Organization launched a global initiative, known as aDSM (active TB drug
safety monitoring and management) to better describe the safety profile of new treatment …
safety monitoring and management) to better describe the safety profile of new treatment …
[HTML][HTML] Treatment outcomes for multidrug-and rifampicin-resistant tuberculosis in Central and West Africa: a systematic review and meta-analysis
…, V Schwoebel, MB Souleymane, A Piubello… - International Journal of …, 2022 - Elsevier
Objectives We aimed to investigate published data on treatment outcomes of multidrug-resistant
(MDR)/rifampicin-resistant tuberculosis (TB) in Central and West Africa because these, …
(MDR)/rifampicin-resistant tuberculosis (TB) in Central and West Africa because these, …
[HTML][HTML] Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: nationwide programmatic achievements
A Piubello, MB Souleymane, S Hassane-Harouna… - Respiratory …, 2020 - Elsevier
Background In Niger, the Shorter Treatment Regimen (STR) has been implemented nationwide
for rifampicin resistant tuberculosis (RR-TB), since 2008. No previous publication has …
for rifampicin resistant tuberculosis (RR-TB), since 2008. No previous publication has …